Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2023 Oct 9;7:e2300472. doi: 10.1200/PO.23.00472

Erratum: Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma

PMCID: PMC11556813  PMID: 37811915

The June 26, 2023 article by Christinat et al entitled “Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma” (JCO Prec Oncol 10.1200/PO.22.00555) was published with errors.

The seventh through fourteenth authors' affiliations were incorrect.

The author list read as:

Yann Christinat, PhD1; Liza Ho, PhD1; Sophie Clément, PhD2; Catherine Genestie, MD, PhD3; Jalid Sehouli, MD, PhD4; Saverio Cinieri, MD, PhD5; Antonio Gonzalez Martin, MD, PhD5; Ursula Denison, MD6; Keiichi Fujiwara, MD, PhD7; Ignace Vergote, MD, PhD8; Germana Tognon, MD9; Sakari Hietanen, MD, PhD10; Isabelle Ray-Coquard, MD, PhD11; Eric Pujade-Lauraine, MD, PhD12; and Thomas A. McKee, MD, PhD1

It should have read as:

Yann Christinat, PhD1; Liza Ho, PhD1; Sophie Clément, PhD2; Catherine Genestie, MD, PhD3; Jalid Sehouli, MD, PhD4; Saverio Cinieri, MD, PhD5; Antonio Gonzalez Martin, MD, PhD6; Ursula Denison, MD7; Keiichi Fujiwara, MD, PhD8; Ignace Vergote, MD, PhD9; Germana Tognon, MD10; Sakari Hietanen, MD, PhD11; Isabelle Ray-Coquard, MD, PhD12; Eric Pujade-Lauraine, MD, PhD13; and Thomas A. McKee, MD, PhD1

This has been corrected as of October 9, 2023. The authors apologize for the errors.


Articles from JCO Precision Oncology are provided here courtesy of Wolters Kluwer Health

RESOURCES